Cover Image
Market Research Report

Osteosarcoma Market Information: By Types, Diagnosis, Treatment, End User - Global Forecast till 2023

Published by Market Research Future Product code 787055
Published Content info 130 Pages
Delivery time: 1-2 business days
Price
Back to Top
Osteosarcoma Market Information: By Types, Diagnosis, Treatment, End User - Global Forecast till 2023
Published: January 31, 2019 Content info: 130 Pages
Description

Osteosarcoma Market Information: By Types (Intramedullary, Juxtacortical, Extra-Skeletal), Diagnosis (Biopsy, X-Ray, CT Scan, Bone Scan, MRI), Treatment (Surgery, Chemotherapy, and others), End User (Hospitals & Clinics, Cancer Research Centers) - Global Forecast till 2023

Market analysis

Osteosarcoma is a kind of bone tumor in which there is a multiplication of osteoblasts. It is one the basic kind of malignant growth prompting the growth of immature bones. The tumor is mostly seen happening in children and adolescents. It is more prevalent in males than females. Juxtacortical osteosarcoma, Intramedullary osteosarcoma, and extraskeletal osteosarcoma are the three kinds of osteosarcomas, among which intramedullary osteosarcoma is the most predominant one. The growing prevalence of the osteosarcoma among the children and teenagers along with the rising demand for the better treatment initiatives are one of the key drivers responsible for the growth of the global osteosarcoma market during the forecast period. The global osteosarcoma market is anticipated to grow at a CAGR of 6.40% during the forecast period (2017-2023).

Market segmentation

The global osteosarcoma market is divided on the basis of its types, treatment, diagnosis, end user and regional demand. Based on its types, the market is segmented into juxtacortical osteosarcoma, intramedullary osteosarcoma, and extra-skeletal osteosarcoma. Based on its treatment, the market is categorized into chemotherapy, radiation therapy, surgery, among others. On the basis of its diagnosis, the market is bifurcated into biopsy, bone scan, MRI, X-ray, CT Scan, and others. On the basis of its end user, the global market is classified into cancer research centers, hospitals & clinics, and others.

Regional analysis

Geographically, the global osteosarcoma market is divided into global regions like Europe, North America, Asia- Pacific, Middle East, LATAM, and Africa.

Major players

Some of the major players in the global osteosarcoma market include companies like Hikma Pharmaceuticals (U.K), Baxter (U.S.), Advaxis Inc., Pfizer (U.S.), Novartis (U.S.), Spectrum Pharmaceuticals, Inc. (U.S.), Isofol Medical AB (Sweden), Bellicum Pharmaceuticals (U.S.), among others.

Table of Contents

Table of Contents

1 Report Prologue

2 Market Introduction

  • 2.1 Definition
  • 2.2 Scope of the Study
    • 2.2.1 Research Objective
    • 2.2.2 Assumptions
    • 2.2.3 Limitations

3 Research Methodology

  • 3.1 Introduction
  • 3.2 Primary Research
  • 3.3 Secondary research
  • 3.4 Market Size Estimation

4 Market Dynamic

  • 4.1 Introduction
  • 4.2 Drivers
    • 4.2.1 Rising prevalence of osteosarcoma (25%)
    • 4.2.2 Increasing expenditure on oncology medicine and research (45%)
    • 4.2.3 Rising demand for new treatment (30%)
  • 4.3 Restraints
    • 4.3.1 High cost of treatment
  • 4.4 Technology Trends and Assessment
  • 4.5 Macroeconomic Indicators

5 Market Factor Analysis

  • 5.1 Value Chain Analysis
    • 5.1.1 Research & Product Development
    • 5.1.2 Formulation
    • 5.1.3 Marketing & Sales
    • 5.1.4 Finish Products
  • 5.2 Porter's Five Forces Model
    • 5.2.1 Bargaining Power of Suppliers
    • 5.2.2 Bargaining Power of Buyers
    • 5.2.3 Threat of New Entrants
    • 5.2.4 Threat of Substitutes
    • 5.2.5 Intensity of Rivalry
  • 5.3 Pricing Analysis
  • 5.4 Investment opportunities

6 Global Osteosarcoma Market, By Type

  • 6.1 Introduction
  • 6.2 Intramedullary Osteosarcoma
  • 6.3 Juxtacortical Osteosarcoma
  • 6.4 Extra-Skeletal Osteosarcoma
  • 6.5 Others

7 Global Osteosarcoma Market, By Diagnosis

  • 7.1 Introduction
  • 7.2 Biopsy
  • 7.3 X-ray
  • 7.4 Magnetic Resonance Imaging (MRI) scan
  • 7.5 Computed Tomography (CT) Scan
  • 7.6 Bone Scan
  • 7.7 Others

8 Global Osteosarcoma Market, By Treatment

  • 8.1 Introduction
  • 8.2 Chemotherapy
  • 8.3 Surgery
  • 8.4 Radiation Therapy
  • 8.5 Others

9 Global Osteosarcoma Market, By End User

  • 9.1 Introduction
  • 9.2 Hospital & Clinics
  • 9.3 Cancer Research Institutes
  • 9.4 Others

10 Global Osteosarcoma Market, By Region

  • 10.1 Introduction
  • 10.2 Americas
    • 10.2.1 U.S.
    • 10.2.2 Canada
    • 10.2.3 South America
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 France
    • 10.3.3 U.K
    • 10.3.4 Italy
    • 10.3.5 Spain
    • 10.3.6 Rest of Western Europe
    • 10.3.7 Eastern Europe
  • 10.4 Asia Pacific
  • 10.5 The Middle East & Africa
    • 10.5.1 UAE
    • 10.5.2 Saudi Arabia
    • 10.5.3 Oman
    • 10.5.4 Kuwait
    • 10.5.5 QATAR
    • 10.5.6 Rest of the Middle East & Africa

11 Company Landscape

  • 11.1 Introduction
  • 11.2 Pipeline Analysis
    • 11.2.1 Active ingredient [6R]-5,10-methylenetetrahydrofolate:
    • 11.2.2 Dinutuximab + Sargramostim:
    • 11.2.3 Hu3F8 + GM-CSF:
  • 11.3 Key Development & Strategies

12 Company Profile

  • 12.1 Pfizer
    • 12.1.1 Company Overview
    • 12.1.2 Financials
    • 12.1.3 Products
    • 12.1.4 Strategy
    • 12.1.5 Key Developments
  • 12.2 Spectrum Pharmaceuticals, Inc.
    • 12.2.1 Company Overview
    • 12.2.2 Financials
    • 12.2.3 Products
    • 12.2.4 Strategy
    • 12.2.5 Key Developments
  • 12.3 Hikma Pharmaceuticals Plc
    • 12.3.1 Company Overview
    • 12.3.2 Financials
    • 12.3.3 Products
    • 12.3.4 Strategy
    • 12.3.5 Key Developments
  • 12.4 Baxter
    • 12.4.1 Company Overview
    • 12.4.2 Financials
    • 12.4.3 Products
    • 12.4.4 Strategy
    • 12.4.5 Key Developments
  • 12.5 ISOFOL
    • 12.5.1 Company Overview
    • 12.5.2 Financials
    • 12.5.3 Products
    • 12.5.4 Strategy
    • 12.5.5 Key Developments
  • 12.6 Advaxis inc.
    • 12.6.1 Company Overview
    • 12.6.2 Financials
    • 12.6.3 Products
    • 12.6.4 Strategy
    • 12.6.5 Key Developments
  • 12.7 Bellicum Pharmaceuticals, Inc
    • 12.7.1 Company Overview
    • 12.7.2 Financials
    • 12.7.3 Products
    • 12.7.4 Strategy
    • 12.7.5 Key Developments
  • 12.8 Novartis
    • 12.8.1 Company Overview
    • 12.8.2 Financials
    • 12.8.3 Products
    • 12.8.4 Strategy
    • 12.8.5 Key Developments

13 Conclusion

  • 13.1 Key Findings
    • 13.1.1 CEO's Viewpoint
    • 13.1.2 Unmet Needs
    • 13.1.3 Key Companies to Watch
    • 13.1.4 Prediction of Osteosarcoma Industry

14 Appendix

  • 14.1 Discussion Blue Print
  • 14.2 References

List of Tables

  • TABLE 1 AVERAGE COST OF TREATMENT PER PATIENT, 2014:
  • TABLE 2 GLOBAL OSTEOSARCOMA MARKET, BY TYPE, 2014-2023 (USD MILLION)
  • TABLE 3 GLOBAL INTRAMEDULLARY OSTEOSARCOMA MARKET, BY REGION, 2014-2023 (USD MILLION)
  • TABLE 4 GLOBAL JUXTACORTICAL OSTEOSARCOMA MARKET, BY REGION, 2014-2023 (USD MILLION)
  • TABLE 5 GLOBAL EXTRASKELETAL OSTEOSARCOMA MARKET, BY REGION, 2014-2023 (USD MILLION)
  • TABLE 6 GLOBAL OTHER OSTEOSARCOMA MARKET, BY REGION, 2014-2023 (USD MILLION)
  • TABLE 7 GLOBAL OSTEOSARCOMA MARKET, BY DIAGNOSIS, 2014-2023 (USD MILLION)
  • TABLE 8 GLOBAL BIOPSY MARKET, BY REGION, 2014-2023 (USD MILLION)
  • TABLE 9 GLOBAL X-RAY MARKET, BY REGION, 2014-2023 (USD MILLION)
  • TABLE 10 GLOBAL MRI MARKET, BY REGION, 2014-2023 (USD MILLION)
  • TABLE 11 GLOBAL CT SCAN MARKET, BY REGION, 2014-2023 (USD MILLION)
  • TABLE 12 GLOBAL BONE SCAN MARKET, BY REGION, 2014-2023 (USD MILLION)
  • TABLE 13 GLOBAL OTHER DIAGNOSIS MARKET, BY REGION, 2014-2023 (USD MILLION)
  • TABLE 14 GLOBAL OSTEOSARCOMA MARKET, BY TREATMENT, 2014-2023 (USD MILLION)
  • TABLE 15 GLOBAL CHEMOTHERAPY MARKET, BY REGION, 2014-2023 (USD MILLION)
  • TABLE 16 GLOBAL SURGERY MARKET, BY REGION, 2014-2023 (USD MILLION)
  • TABLE 17 GLOBAL RADIATION THERAPY MARKET, BY REGION, 2014-2023 (USD MILLION)
  • TABLE 18 GLOBAL OTHER TREATMENT MARKET, BY REGION, 2014-2023 (USD MILLION)
  • TABLE 19 GLOBAL OSTEOSARCOMA MARKET, BY END USER, 2014-2023 (USD MILLION)
  • TABLE 20 GLOBAL HOSPITAL AND CLINICS MARKET, BY REGION, 2014-2023 (USD MILLION)
  • TABLE 21 GLOBAL CANCER RESEARCH INSTITUTE, BY REGION, 2014-2023 (USD MILLION)
  • TABLE 22 GLOBAL OTHER END USERS, BY REGION, 2014-2023 (USD MILLION)
  • TABLE 23 GLOBAL OSTEOSARCOMA MARKET, BY REGION, 2014-2023 (USD MILLION)
  • TABLE 24 AMERICAS OSTEOSARCOMA MARKET, BY REGION, 2014-2023 (USD MILLION)
  • TABLE 25 NORTH AMERICA OSTEOSARCOMA MARKET, BY REGION, 2014-2023 (USD MILLION)
  • TABLE 26 AMERICAS OSTEOSARCOMA MARKET, BY TYPE, 2014-2023 (USD MILLION)
  • TABLE 27 AMERICAS OSTEOSARCOMA MARKET, BY DIAGNOSIS, 2014-2023 (USD MILLION)
  • TABLE 28 AMERICAS OSTEOSARCOMA MARKET, BY TREATMENT, 2014-2023 (USD MILLION)
  • TABLE 29 AMERICAS OSTEOSARCOMA MARKET, BY END USER, 2014-2023 (USD MILLION)
  • TABLE 30 U.S. OSTEOSARCOMA MARKET, BY TYPE, 2014-2023 (USD MILLION)
  • TABLE 31 U.S. OSTEOSARCOMA MARKET, BY DIAGNOSIS, 2014-2023 (USD MILLION)
  • TABLE 32 U.S. OSTEOSARCOMA MARKET, BY TREATMENT, 2014-2023 (USD MILLION)
  • TABLE 33 U.S. OSTEOSARCOMA MARKET, BY END USER, 2014-2023 (USD MILLION)
  • TABLE 34 CANADA OSTEOSARCOMA MARKET, BY TYPE, 2014-2023 (USD MILLION)
  • TABLE 35 CANADA OSTEOSARCOMA MARKET, BY DIAGNOSIS, 2014-2023 (USD MILLION)
  • TABLE 36 CANADA OSTEOSARCOMA MARKET, BY TREATMENT, 2014-2023 (USD MILLION)
  • TABLE 37 CANADA OSTEOSARCOMA MARKET, BY END USER, 2014-2023 (USD MILLION)
  • TABLE 38 SOUTH AMERICA OSTEOSARCOMA MARKET, BY TYPE, 2014-2023 (USD MILLION)
  • TABLE 39 SOUTH AMERICA OSTEOSARCOMA MARKET, BY DIAGNOSIS, 2014-2023 (USD MILLION)
  • TABLE 40 SOUTH AMERICA OSTEOSARCOMA MARKET, BY TREATMENT, 2014-2023 (USD MILLION)
  • TABLE 41 SOUTH AMERICA OSTEOSARCOMA MARKET, BY END USER, 2014-2023 (USD MILLION)
  • TABLE 42 EUROPE OSTEOSARCOMA MARKET, BY REGION, 2014-2023 (USD MILLION)
  • TABLE 43 WESTERN EUROPE OSTEOSARCOMA MARKET, BY COUNTRY, 2014-2023 (USD MILLION)
  • TABLE 44 EUROPE OSTEOSARCOMA MARKET, BY TYPE, 2014-2023 (USD MILLION)
  • TABLE 45 EUROPE OSTEOSARCOMA MARKET, BY DIAGNOSIS, 2014-2023 (USD MILLION)
  • TABLE 46 EUROPE OSTEOSARCOMA MARKET, BY TREATMENT, 2014-2023 (USD MILLION)
  • TABLE 47 EUROPE OSTEOSARCOMA MARKET, BY END USER, 2014-2023 (USD MILLION)
  • TABLE 48 GERMANY OSTEOSARCOMA MARKET, BY TYPE, 2014-2023 (USD MILLION)
  • TABLE 49 GERMANY OSTEOSARCOMA MARKET, BY DIAGNOSIS, 2014-2023 (USD MILLION)
  • TABLE 50 GERMANY OSTEOSARCOMA MARKET, BY TREATMENT, 2014-2023 (USD MILLION)
  • TABLE 51 GERMANY OSTEOSARCOMA MARKET, BY END USER, 2014-2023 (USD MILLION)
  • TABLE 52 FRANCE OSTEOSARCOMA MARKET, BY TYPE, 2014-2023 (USD MILLION)
  • TABLE 53 FRANCE OSTEOSARCOMA MARKET, BY DIAGNOSIS, 2014-2023 (USD MILLION)
  • TABLE 54 FRANCE OSTEOSARCOMA MARKET, BY TREATMENT, 2014-2023 (USD MILLION)
  • TABLE 55 FRANCE OSTEOSARCOMA MARKET, BY END USER, 2014-2023 (USD MILLION)
  • TABLE 56 U.K OSTEOSARCOMA MARKET, BY TYPE, 2014-2023 (USD MILLION)
  • TABLE 57 U.K OSTEOSARCOMA MARKET, BY DIAGNOSIS, 2014-2023 (USD MILLION)
  • TABLE 58 U.K OSTEOSARCOMA MARKET, BY TREATMENT, 2014-2023 (USD MILLION)
  • TABLE 59 U.K OSTEOSARCOMA MARKET, BY END USER, 2014-2023 (USD MILLION)
  • TABLE 60 ITALY OSTEOSARCOMA MARKET, BY TYPE, 2014-2023 (USD MILLION)
  • TABLE 61 ITALY OSTEOSARCOMA MARKET, BY DIAGNOSIS, 2014-2023 (USD MILLION)
  • TABLE 62 ITALY OSTEOSARCOMA MARKET, BY TREATMENT, 2014-2023 (USD MILLION)
  • TABLE 63 ITALY OSTEOSARCOMA MARKET, BY END USER, 2014-2023 (USD MILLION)
  • TABLE 64 SPAIN OSTEOSARCOMA MARKET, BY TYPE, 2014-2023 (USD MILLION)
  • TABLE 65 SPAIN OSTEOSARCOMA MARKET, BY DIAGNOSIS, 2014-2023 (USD MILLION)
  • TABLE 66 SPAIN OSTEOSARCOMA MARKET, BY TREATMENT, 2014-2023 (USD MILLION)
  • TABLE 67 SPAIN OSTEOSARCOMA MARKET, BY END USER, 2014-2023 (USD MILLION)
  • TABLE 68 REST OF WESTERN EUROPE OSTEOSARCOMA MARKET, BY TYPE, 2014-2023 (USD MILLION)
  • TABLE 69 REST OF WESTERN EUROPE OSTEOSARCOMA MARKET, BY DIAGNOSIS, 2014-2023 (USD MILLION)
  • TABLE 70 REST OF WESTERN EUROPE OSTEOSARCOMA MARKET, BY TREATMENT, 2014-2023 (USD MILLION)
  • TABLE 71 REST OF WESTERN EUROPE OSTEOSARCOMA MARKET, BY END USER, 2014-2023 (USD MILLION)
  • TABLE 72 EASTERN EUROPE OSTEOSARCOMA MARKET, BY TYPE, 2014-2023 (USD MILLION)
  • TABLE 73 EASTERN EUROPE OSTEOSARCOMA MARKET, BY DIAGNOSIS, 2014-2023 (USD MILLION)
  • TABLE 74 EASTERN EUROPE OSTEOSARCOMA MARKET, BY TREATMENT, 2014-2023 (USD MILLION)
  • TABLE 75 EASTERN EUROPE OSTEOSARCOMA MARKET, BY END USER, 2014-2023 (USD MILLION)
  • TABLE 76 ASIA PACIFIC OSTEOSARCOMA MARKET, BY COUNTRY, 2014-2023 (USD MILLION)
  • TABLE 77 ASIA PACIFIC OSTEOSARCOMA MARKET, BY TYPE, 2014-2023 (USD MILLION)
  • TABLE 78 ASIA PACIFIC OSTEOSARCOMA MARKET, BY DIAGNOSIS, 2014-2023 (USD MILLION)
  • TABLE 79 ASIA PACIFIC OSTEOSARCOMA MARKET, BY TREATMENT, 2014-2023 (USD MILLION)
  • TABLE 80 ASIA PACIFIC OSTEOSARCOMA MARKET, BY END USER, 2014-2023 (USD MILLION)
  • TABLE 81 JAPAN OSTEOSARCOMA MARKET, BY TYPE, 2014-2023 (USD MILLION)
  • TABLE 82 JAPAN OSTEOSARCOMA MARKET, BY DIAGNOSIS, 2014-2023 (USD MILLION)
  • TABLE 83 JAPAN OSTEOSARCOMA MARKET, BY TREATMENT, 2014-2023 (USD MILLION)
  • TABLE 84 JAPAN OSTEOSARCOMA MARKET, BY END USER, 2014-2023 (USD MILLION)
  • TABLE 85 CHINA OSTEOSARCOMA MARKET, BY TYPE, 2014-2023 (USD MILLION)
  • TABLE 86 CHINA OSTEOSARCOMA MARKET, BY DIAGNOSIS, 2014-2023 (USD MILLION)
  • TABLE 87 CHINA OSTEOSARCOMA MARKET, BY TREATMENT, 2014-2023 (USD MILLION)
  • TABLE 88 CHINA OSTEOSARCOMA MARKET, BY END USER, 2014-2023 (USD MILLION)
  • TABLE 89 INDIA OSTEOSARCOMA MARKET, BY TYPE, 2014-2023 (USD MILLION)
  • TABLE 90 INDIA OSTEOSARCOMA MARKET, BY DIAGNOSIS, 2014-2023 (USD MILLION)
  • TABLE 91 INDIA OSTEOSARCOMA MARKET, BY TREATMENT, 2014-2023 (USD MILLION)
  • TABLE 92 INDIA OSTEOSARCOMA MARKET, BY END USER, 2014-2023 (USD MILLION)
  • TABLE 93 AUSTRALIA OSTEOSARCOMA MARKET, BY TYPE, 2014-2023 (USD MILLION)
  • TABLE 94 AUSTRALIA OSTEOSARCOMA MARKET, BY DIAGNOSIS, 2014-2023 (USD MILLION)
  • TABLE 95 AUSTRALIA OSTEOSARCOMA MARKET, BY TREATMENT, 2014-2023 (USD MILLION)
  • TABLE 96 AUSTRALIA OSTEOSARCOMA MARKET, BY END USER, 2014-2023 (USD MILLION)
  • TABLE 97 REPUBLIC OF KOREA OSTEOSARCOMA MARKET, BY TYPE, 2014-2023 (USD MILLION)
  • TABLE 98 REPUBLIC OF KOREA OSTEOSARCOMA MARKET, BY DIAGNOSIS, 2014-2023 (USD MILLION)
  • TABLE 99 REPUBLIC OF KOREA OSTEOSARCOMA MARKET, BY TREATMENT, 2014-2023 (USD MILLION)
  • TABLE 100 REPUBLIC OF KOREA OSTEOSARCOMA MARKET, BY END USER, 2014-2023 (USD MILLION)
  • TABLE 101 REST OF ASIA PACIFIC OSTEOSARCOMA MARKET, BY TYPE, 2014-2023 (USD MILLION)
  • TABLE 102 REST OF ASIA PACIFIC OSTEOSARCOMA MARKET, BY DIAGNOSIS, 2014-2023 (USD MILLION)
  • TABLE 103 REST OF ASIA PACIFIC OSTEOSARCOMA MARKET, BY TREATMENT, 2014-2023 (USD MILLION)
  • TABLE 104 REST OF ASIA PACIFIC OSTEOSARCOMA MARKET, BY END USER, 2014-2023 (USD MILLION)
  • TABLE 105 MIDDLE EAST & AFRICA OSTEOSARCOMA MARKET, BY COUNTRY, 2014-2023 (USD MILLION)
  • TABLE 106 MIDDLE EAST & AFRICA OSTEOSARCOMA MARKET, BY TYPE, 2014-2023 (USD MILLION)
  • TABLE 107 MIDDLE EAST & AFRICA OSTEOSARCOMA MARKET, BY DIAGNOSIS, 2014-2023 (USD MILLION)
  • TABLE 108 MIDDLE EAST & AFRICA OSTEOSARCOMA MARKET, BY TREATMENT, 2014-2023 (USD MILLION)
  • TABLE 109 MIDDLE EAST & AFRICA OSTEOSARCOMA MARKET, BY END USER, 2014-2023 (USD MILLION)
  • TABLE 110 UAE OSTEOSARCOMA MARKET, BY TYPE, 2014-2023 (USD MILLION)
  • TABLE 111 UAE OSTEOSARCOMA MARKET, BY DIAGNOSIS, 2014-2023 (USD MILLION)
  • TABLE 112 UAE OSTEOSARCOMA MARKET, BY TREATMENT, 2014-2023 (USD MILLION)
  • TABLE 113 UAE OSTEOSARCOMA MARKET, BY END USER, 2014-2023 (USD MILLION)
  • TABLE 114 SAUDI ARABIA OSTEOSARCOMA MARKET, BY TYPE, 2014-2023 (USD MILLION)
  • TABLE 115 SAUDI ARABIA OSTEOSARCOMA MARKET, BY DIAGNOSIS, 2014-2023 (USD MILLION)
  • TABLE 116 SAUDI ARABIA OSTEOSARCOMA MARKET, BY TREATMENT, 2014-2023 (USD MILLION)
  • TABLE 117 SAUDI ARABIA OSTEOSARCOMA MARKET, BY END USER, 2014-2023 (USD MILLION)
  • TABLE 118 OMAN OSTEOSARCOMA MARKET, BY TYPE, 2014-2023 (USD MILLION)
  • TABLE 119 OMAN OSTEOSARCOMA MARKET, BY DIAGNOSIS, 2014-2023 (USD MILLION)
  • TABLE 120 OMAN OSTEOSARCOMA MARKET, BY TREATMENT, 2014-2023 (USD MILLION)
  • TABLE 121 OMAN OSTEOSARCOMA MARKET, BY END USER, 2014-2023 (USD MILLION)
  • TABLE 122 KUWAIT OSTEOSARCOMA MARKET, BY TYPE, 2014-2023 (USD MILLION)
  • TABLE 123 KUWAIT OSTEOSARCOMA MARKET, BY DIAGNOSIS, 2014-2023 (USD MILLION)
  • TABLE 124 KUWAIT OSTEOSARCOMA MARKET, BY TREATMENT, 2014-2023 (USD MILLION)
  • TABLE 125 KUWAIT OSTEOSARCOMA MARKET, BY END USER, 2014-2023 (USD MILLION)
  • TABLE 126 QATAR OSTEOSARCOMA MARKET, BY TYPE, 2014-2023 (USD MILLION)
  • TABLE 127 QATAR OSTEOSARCOMA MARKET, BY DIAGNOSIS, 2014-2023 (USD MILLION)
  • TABLE 128 QATAR OSTEOSARCOMA MARKET, BY TREATMENT, 2014-2023 (USD MILLION)
  • TABLE 129 QATAR OSTEOSARCOMA MARKET, BY END USER, 2014-2023 (USD MILLION)
  • TABLE 130 REST OF THE MIDDLE EAST & AFRICA OSTEOSARCOMA MARKET, BY TYPE, 2014-2023 (USD MILLION)
  • TABLE 131 REST OF THE MIDDLE EAST & AFRICA OSTEOSARCOMA MARKET, BY DIAGNOSIS, 2014-2023 (USD MILLION)
  • TABLE 132 REST OF THE MIDDLE EAST & AFRICA OSTEOSARCOMA MARKET, BY TREATMENT, 2014-2023 (USD MILLION)
  • TABLE 133 REST OF THE MIDDLE EAST & AFRICA OSTEOSARCOMA MARKET, BY END USER, 2014-2023 (USD MILLION)
  • TABLE 134 GLOBAL OSTEOSARCOMA MARKET, PIPELINE ANALYSIS
  • TABLE 135 KEY DEVEOPMENTS

List of Figures

  • FIGURE 1 GLOBAL OSTEOSARCOMA MARKET SHARE, BY TYPE, 2016 (%)
  • FIGURE 2 GLOBAL OSTEOSARCOMA MARKET SHARE, BY DIAGNOSIS, 2016 (%)
  • FIGURE 3 GLOBAL OSTEOSARCOMA MARKET BY TREATMENT, 2016 (%)
  • FIGURE 4 GLOBAL OSTEOSARCOMA MARKET BY END USER, 2016 (%)
  • FIGURE 5 GLOBAL OSTEOSARCOMA MARKET BY REGION, 2016 (%)
  • FIGURE 6 MARKET STRUCTURE
  • FIGURE 7 RESEARCH PROCESS
  • FIGURE 8 FORECAST MODEL
  • FIGURE 9 VALUE CHAIN: OSTEOSARCOMA CANCER MARKET
  • FIGURE 10 PORTER'S FIVE FORCES MODEL
  • FIGURE 11 GLOBAL OSTEOSARCOMA MARKET, BY PRODUCT TYPE, 2016 & 2023 (USD MILLION)
  • FIGURE 12 GLOBAL OSTEOSARCOMA MARKET, BY DIAGNOSIS, 2016 & 2023 (USD MILLION)
  • FIGURE 13 GLOBAL OSTEOSARCOMA MARKET, BY TREATMENT, 2016 & 2023 (USD MILLION)
  • FIGURE 14 GLOBAL OSTEOSARCOMA MARKET, BY END USER, 2016 & 2023 (USD MILLION)
  • FIGURE 15 GLOBAL OSTEOSARCOMA MARKET, BY END USER, 2016 & 2023 (USD MILLION)
  • FIGURE 16 AMERICAS OSTEOSARCOMA MARKET, BY REGION, 2016 (%)
  • FIGURE 17 EUROPE OSTEOSARCOMA MARKET, BY REGION, 2016 (%)
  • FIGURE 18 ASIA PACIFIC OSTEOSARCOMA MARKET, BY COUNTRY, 2016 (%)
  • FIGURE 19 MIDDLE EAST & AFRICA OSTEOSARCOMA MARKET, BY COUNTRY, 2016 (%)
Back to Top